Translate page

  • Presentations from the EHA2022 Congress

  • EHA 2022: Mechanisms of disease progression in chronic myeloid leukemia (S. Tiong Ong)

  • EHA 2022: Non-BCR-ABL1 biomarkers of prognosis in CML (Shady Awad)

  • COLT Meeting 2019: CML related topics

  • COLT Meeting 2019: The CML frontier

    iCMLf Diagnosis and Testing Program: Apply now for 2015 grantsFirstTest

    Extended deadline for applications: July 10, 2015 

    April 2015 - The iCMLf Diagnosis and Testing Program offers seeding grants to hematology institutions in emerging economic regions. The aim of the program is to facilitate the diagnosis, testing and long-term disease monitoring of CML patients in emerging economic regions where it is not currently available. 
    Building on the success of the previous twenty-two projects awarded iCMLf grants, the Foundation will offer further funding in 2015 for up to 10 new proposals with a funding of $10,000.

    Expressions of interest are welcome to
    Applications close on the 10th of July 2015.

    Through the Diagnosis and Testing Program the iCMLf will assist centres in emerging economic regions enhance facilities at a local level to either bring high quality testing to the patient, or to develop a low cost strategy for sending patient samples to a central reference laboratory for testing. Developing local diagnostic capacity and resource sustainability are important criteria for the iCMLf grants.
    Institutions awarded grants will partner with a CML centre of excellence to ensure the successful implementation of the proposal and offer ongoing mentoring and support at a clinical and laboratory level.

    Full application and eligibility criteria for the grants can be found on the ‘program information’ here:

    Along with the application form here:

    All questions and submissions should be addressed to: